Denali Therapeutics Inc. DNLI Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s convertible preferred stock authorized shares?
- Denali Therapeutics Inc. (DNLI) reported convertible preferred stock authorized shares of 40M in Q1 2026.
- How has Denali Therapeutics Inc.'s convertible preferred stock authorized shares changed year-over-year?
- Denali Therapeutics Inc.'s convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 40M to 40M.
- What is the long-term trend for Denali Therapeutics Inc.'s convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 40M to 40M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.